Partnerships, Knowledge Sharing Can Advance Contraceptive R&D

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Connecting the Dots: Advancing Contraceptive R&D through Partnerships and Knowledge Sharing
Laneta Dorflinger, director of contraceptive technology at FHI 360; Kate Rademacher, technical adviser in FHI 360’s global health, population, and nutrition group; and Lucy Wilson, monitoring and evaluation adviser for contraceptive technology innovation at FHI 360, describe the financial and regulatory barriers to advancing new contraceptive methods through the R&D pipeline, as well as the Contraceptive Technology Innovation (CTI) Exchange, a website platform for individuals to share resources and information on contraceptive R&D (7/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.